224 related articles for article (PubMed ID: 37158247)
1. ACFIS 2.0: an improved web-server for fragment-based drug discovery via a dynamic screening strategy.
Shi XX; Wang ZZ; Wang F; Hao GF; Yang GF
Nucleic Acids Res; 2023 Jul; 51(W1):W25-W32. PubMed ID: 37158247
[TBL] [Abstract][Full Text] [Related]
2. ACFIS: a web server for fragment-based drug discovery.
Hao GF; Jiang W; Ye YN; Wu FX; Zhu XL; Guo FB; Yang GF
Nucleic Acids Res; 2016 Jul; 44(W1):W550-6. PubMed ID: 27150808
[TBL] [Abstract][Full Text] [Related]
3. Fragment-based approaches to anti-HIV drug discovery: state of the art and future opportunities.
Huang B; Kang D; Zhan P; Liu X
Expert Opin Drug Discov; 2015 Dec; 10(12):1271-81. PubMed ID: 26372893
[TBL] [Abstract][Full Text] [Related]
4. A fragment-based drug discovery developed on ciclopirox for inhibition of Hepatitis B virus core protein: An in silico study.
Mohebbi A; Ghorbanzadeh T; Naderifar S; Khalaj F; Askari FS; Sammak AS
PLoS One; 2023; 18(5):e0285941. PubMed ID: 37196004
[TBL] [Abstract][Full Text] [Related]
5. Post processing of protein-compound docking for fragment-based drug discovery (FBDD): in-silico structure-based drug screening and ligand-binding pose prediction.
Fukunishi Y
Curr Top Med Chem; 2010; 10(6):680-94. PubMed ID: 20337587
[TBL] [Abstract][Full Text] [Related]
6. Perspectives on Fragment-based Drug Discovery: A Strategy Applicable to Diverse Targets.
Li Q; Kang C
Curr Top Med Chem; 2021; 21(13):1099-1112. PubMed ID: 34348623
[TBL] [Abstract][Full Text] [Related]
7. [Fragment-based drug discovery: concept and aim].
Tanaka D
Yakugaku Zasshi; 2010 Mar; 130(3):315-23. PubMed ID: 20190516
[TBL] [Abstract][Full Text] [Related]
8. Crystallographic fragment screening in academic cancer drug discovery.
Martin MP; Endicott JA; Noble MEM; Tatum NJ
Methods Enzymol; 2023; 690():211-234. PubMed ID: 37858530
[TBL] [Abstract][Full Text] [Related]
9. Fragments: where are we now?
Osborne J; Panova S; Rapti M; Urushima T; Jhoti H
Biochem Soc Trans; 2020 Feb; 48(1):271-280. PubMed ID: 31985743
[TBL] [Abstract][Full Text] [Related]
10. Fragment informatics and computational fragment-based drug design: an overview and update.
Sheng C; Zhang W
Med Res Rev; 2013 May; 33(3):554-98. PubMed ID: 22430881
[TBL] [Abstract][Full Text] [Related]
11. In silico fragment-mapping method: a new tool for fragment-based/structure-based drug discovery.
Yamaotsu N; Hirono S
J Comput Aided Mol Des; 2018 Nov; 32(11):1229-1245. PubMed ID: 30196523
[TBL] [Abstract][Full Text] [Related]
12. HISNAPI: a bioinformatic tool for dynamic hot spot analysis in nucleic acid-protein interface with a case study.
Mei LC; Wang YL; Wu FX; Wang F; Hao GF; Yang GF
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406224
[TBL] [Abstract][Full Text] [Related]
13. Effective progression of nuclear magnetic resonance-detected fragment hits.
Eaton HL; Wyss DF
Methods Enzymol; 2011; 493():447-68. PubMed ID: 21371601
[TBL] [Abstract][Full Text] [Related]
14. Fragment-based drug discovery and molecular docking in drug design.
Wang T; Wu MB; Chen ZJ; Chen H; Lin JP; Yang LR
Curr Pharm Biotechnol; 2015; 16(1):11-25. PubMed ID: 25420726
[TBL] [Abstract][Full Text] [Related]
15. [In-silico approaches for fragment-based drug design].
Takahashi O; Masuda Y; Muroya A; Furuya T
Yakugaku Zasshi; 2010 Mar; 130(3):349-54. PubMed ID: 20190520
[TBL] [Abstract][Full Text] [Related]
16. Cloud 3D-QSAR: a web tool for the development of quantitative structure-activity relationship models in drug discovery.
Wang YL; Wang F; Shi XX; Jia CY; Wu FX; Hao GF; Yang GF
Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33140820
[TBL] [Abstract][Full Text] [Related]
17. Fragment-based drug discovery using rational design.
Jhoti H
Ernst Schering Found Symp Proc; 2007; (3):169-85. PubMed ID: 18510103
[TBL] [Abstract][Full Text] [Related]
18. Applied Biophysical Methods in Fragment-Based Drug Discovery.
Coyle J; Walser R
SLAS Discov; 2020 Jun; 25(5):471-490. PubMed ID: 32345095
[TBL] [Abstract][Full Text] [Related]
19. Hit triage using efficiency indices after screening of compound libraries in drug discovery.
Reitz AB; Smith GR; Tounge BA; Reynolds CH
Curr Top Med Chem; 2009; 9(18):1718-24. PubMed ID: 19929837
[TBL] [Abstract][Full Text] [Related]
20. Counting on Fragment Based Drug Design Approach for Drug Discovery.
Kashyap A; Singh PK; Silakari O
Curr Top Med Chem; 2018; 18(27):2284-2293. PubMed ID: 30499406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
